Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
NCT01802073
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Primary Sclerosing Cholangitis
Interventions
DRUG:
Oral Vancomycin
Sponsor
Stanford University